Quantum BioPharma Ltd. (CSE:QNTM)
Canada · Delayed Price · Currency is CAD 5.31
+0.80 (17.74%)
At close: Aug 14, 2026
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of CAD 33.98 million as of August 14, 2026. Its market cap has decreased by -71.73% in one year.
Market Cap
33.98M
Enterprise Value
27.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.31
ChartMarket Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from 158.35M to 33.98M, a decrease of -78.54%. That is a compound annual growth rate of -17.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 33.98M | -15.61% |
| Dec 31, 2025 | 40.26M | 301.84% |
| Dec 31, 2024 | 10.02M | -78.79% |
| Dec 29, 2023 | 47.25M | 18.00% |
| Dec 30, 2022 | 40.04M | -24.98% |
| Dec 31, 2021 | 53.38M | 39.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 39.89M |
| Medicenna Therapeutics | 36.92M |
| Onco-Innovations | 36.89M |
| Resverlogix | 36.10M |
| Telescope Innovations | 34.35M |
| Defence Therapeutics | 30.69M |
| Sharp Therapeutics | 27.37M |
| Alzai Health | 22.77M |